Definium Therapeutics, Inc. (DFTX) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$183.79M | -69.1% |
| 2024 | -$108.68M | -13.5% |
| 2023 | -$95.73M | -68.6% |
| 2022 | -$56.80M | +39.0% |
| 2021 | -$93.04M | -174.1% |
| 2020 | -$33.94M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$183.79M | -69.1% |
| 2024 | -$108.68M | -13.5% |
| 2023 | -$95.73M | -68.6% |
| 2022 | -$56.80M | +39.0% |
| 2021 | -$93.04M | -174.1% |
| 2020 | -$33.94M | — |